Cargando…

Transcriptome and genome evolution during HER2-amplified breast neoplasia

BACKGROUND: The acquisition of oncogenic drivers is a critical feature of cancer progression. For some carcinomas, it is clear that certain genetic drivers occur early in neoplasia and others late. Why these drivers are selected and how these changes alter the neoplasia’s fitness is less understood....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Peipei, Foley, Joseph, Zhu, Chunfang, McNamara, Katherine, Sirinukunwattana, Korsuk, Vennam, Sujay, Varma, Sushama, Fehri, Hamid, Srivastava, Arunima, Zhu, Shirley, Rittscher, Jens, Mallick, Parag, Curtis, Christina, West, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281634/ https://www.ncbi.nlm.nih.gov/pubmed/34266469 http://dx.doi.org/10.1186/s13058-021-01451-6

Ejemplares similares

Self-Organizing Maps for Cellular In Silico Staining and Cell Substate Classification
por: Yuan, Edwin, et al.
Publicado: (2021)

Precision immunoprofiling by image analysis and artificial intelligence
por: Koelzer, Viktor H., et al.
Publicado: (2018)

The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling
por: Tay, Joshua K., et al.
Publicado: (2022)

A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions
por: Brunner, Alayne L, et al.
Publicado: (2014)

Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas
por: Przybyl, Joanna, et al.
Publicado: (2019)

The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer
por: Ghosh, Abhisek, et al.
Publicado: (2021)

Automated quality assessment of large digitised histology cohorts by artificial intelligence
por: Haghighat, Maryam, et al.
Publicado: (2022)

Gene expression profiling of single cells from archival tissue with laser-capture microdissection and Smart-3SEQ
por: Foley, Joseph W., et al.
Publicado: (2019)

Digital pathology: 15th European congress, ECDP 2019, Warwick, UK, april 10-13, 2019, proceedings
por: Reyes-Aldasoro, Constantino Carlos, et al.
Publicado: (2019)

Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies
por: Chatrian, Andrea, et al.
Publicado: (2021)

Bayesian Hierarchical Clustering for Studying Cancer Gene Expression Data with Unknown Statistics
por: Sirinukunwattana, Korsuk, et al.
Publicado: (2013)

HER-3 expression in HER-2-amplified breast carcinoma
por: Czopek, Jacek, et al.
Publicado: (2013)

Robust normalization protocols for multiplexed fluorescence bioimage analysis
por: Ahmed Raza, Shan E, et al.
Publicado: (2016)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)

Novel digital signatures of tissue phenotypes for predicting distant metastasis in colorectal cancer
por: Sirinukunwattana, Korsuk, et al.
Publicado: (2018)

Glandular Morphometrics for Objective Grading of Colorectal Adenocarcinoma Histology Images
por: Awan, Ruqayya, et al.
Publicado: (2017)

Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers
por: Campbell, Marcia R., et al.
Publicado: (2022)

Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
por: Ryou, Hosuk, et al.
Publicado: (2023)

Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients
por: Ryou, Hosuk, et al.
Publicado: (2022)

Clinical and molecular characterization of HER2 amplified-pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2013)

Inactivating Amplified HER2: Challenges, Dilemmas, and Future Directions
por: Moasser, Mark M.
Publicado: (2022)

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors
por: Floros, Konstantinos V., et al.
Publicado: (2021)

Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women
por: Bel Haj Rhouma, Rahima, et al.
Publicado: (2021)

Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia
por: Weng, Ziming, et al.
Publicado: (2015)

Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
por: Risom, Tyler, et al.
Publicado: (2022)

Imitating Pathologist Based Assessment With Interpretable and Context Based Neural Network Modeling of Histology Images
por: Srivastava, Arunima, et al.
Publicado: (2018)

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
por: Canonici, Alexandra, et al.
Publicado: (2013)

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
por: Tschui, J., et al.
Publicado: (2015)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer
por: Ning, Gang, et al.
Publicado: (2021)

Antibody–Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors
por: McNamara, Blair, et al.
Publicado: (2023)

Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment
por: Dennie, Trevor
Publicado: (2015)

Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells
por: Yoshioka, Takahiro, et al.
Publicado: (2019)

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma
por: Wang, Qinyang, et al.
Publicado: (2022)

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
por: Galdy, Salvatore, et al.
Publicado: (2016)

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
por: Luque-Cabal, María, et al.
Publicado: (2016)

Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer
por: Verschoor, Noortje, et al.
Publicado: (2023)

HER2 Amplification by Next-Generation Sequencing in Lung Carcinoma: A Comparison of NGS Amplified and Non-amplified Cases by Immunohistochemistry and In Situ Hybridization
por: Kıvrak, Hale, et al.
Publicado: (2022)

Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling
por: Riordan, Daniel P., et al.
Publicado: (2015)

Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancer
por: Saffari, Persiana S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gn5s3ira9t5i1lqvfuhmckc3fj